This is an excellent point of course which I might use to highlight an unexpected consequence of homeostasis. When the science demonstrates Restore/Regen properties in the right context then chain events may develop. When the investing public sees the possibilities of multiple-chained successes in CNS diseases, all of which currently have no effective treatments, then exponential SP growth is possible. Not sure who will bring it up first, I suspect some fund will see the multiplier effect. SP will increase at an increasing rate when the science demonstrates linked capabilities. As one solution is validated then expectations for more linked successes in other indications is a possible. The share price may then get out in front of the science, the opposite of where we are now.
I realize it sounds a little strange but, so what.